Literature DB >> 10429967

Subcellular distribution of S100 proteins in tumor cells and their relocation in response to calcium activation.

A Mueller1, T Bächi, M Höchli, B W Schäfer, C W Heizmann.   

Abstract

S100 proteins, a subgroup of the EF-hand Ca2+-binding protein family, regulate a variety of cellular processes via interaction with different target proteins. Several pathological disorders, including cancer, are linked to altered Ca2+ homeostasis and might involve the multifunctional S100 proteins, which are expressed in a cell- and tissue-specific manner. The present work demonstrates a distinct intracellular localization of S100A6, S100A4, and S100A2 in two tumor cell lines derived from metastatic epithelial breast adenocarcinoma (MDA-MB231) and cervical carcinoma (HeLa). Treatment of the cells by thapsigargin, the ionophore A23187, or cyclic ADP-ribose, to increase [Ca2+]i via different pathways, led to relocation of S100A6 and S100A4 but only partially of the nuclear S100A2, as demonstrated by confocal laser scanning microscopy. These findings support the hypothesis that S100 proteins could play a crucial role in the regulation of Ca2+ homeostasis in cancer cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10429967     DOI: 10.1007/s004180050381

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  16 in total

1.  Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex.

Authors:  Hongjie Shen; Wenqi Xu; Rui Guo; Bowen Rong; Lei Gu; Zhentian Wang; Chenxi He; Lijuan Zheng; Xin Hu; Zhen Hu; Zhi-Ming Shao; Pengyuan Yang; Feizhen Wu; Yujiang Geno Shi; Yang Shi; Fei Lan
Journal:  Cell       Date:  2016-04-07       Impact factor: 41.582

2.  Expression of calcium-binding proteins S100A2 and S100A4 in Barrett's adenocarcinomas.

Authors:  Ok-Jae Lee; Seung-Mo Hong; Mohammad H Razvi; Dunfa Peng; Steven M Powell; Mark Smoklin; Christopher A Moskaluk; Wael El-Rifai
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

Review 3.  Calcium-binding proteins: distribution and implication in mammalian placenta.

Authors:  Louiza Belkacemi; Lucie Simoneau; Julie Lafond
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 4.  Calcium in tumour metastasis: new roles for known actors.

Authors:  Natalia Prevarskaya; Roman Skryma; Yaroslav Shuba
Journal:  Nat Rev Cancer       Date:  2011-07-22       Impact factor: 60.716

5.  Psoriasin (S100A7) expression is altered during skin tumorigenesis.

Authors:  Salem Alowami; Gefei Qing; Ethan Emberley; Linda Snell; Peter H Watson
Journal:  BMC Dermatol       Date:  2003-02-24

6.  The S100A7 nuclear interactors in autoimmune diseases: a coevolutionary study in mammals.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Massimo Libra
Journal:  Immunogenetics       Date:  2022-02-16       Impact factor: 2.846

Review 7.  Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks?

Authors:  Natalia Prevarskaya; Halima Ouadid-Ahidouch; Roman Skryma; Yaroslav Shuba
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

8.  S100A6 is a positive regulator of PPP5C-FKBP51-dependent regulation of endothelial calcium signaling.

Authors:  Barnita Haldar; Caleb L Hamilton; Viktoriya Solodushko; Kevin A Abney; Mikhail Alexeyev; Richard E Honkanen; Jonathan G Scammell; Donna L Cioffi
Journal:  FASEB J       Date:  2020-01-09       Impact factor: 5.191

9.  Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer.

Authors:  Jodie M Fleming; Erika Ginsburg; Shannon D Oliver; Paul Goldsmith; Barbara K Vonderhaar
Journal:  BMC Cancer       Date:  2012-06-22       Impact factor: 4.430

10.  Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma.

Authors:  Panagiotis Hountis; Periklis G Foukas; Dimitrios Matthaios; Maria Kefala; Leonidas Chelis; Aikaterini Pantelidaki; Ioannis G Panayiotides; Petros Karakitsos; Stylianos Kakolyris
Journal:  Onco Targets Ther       Date:  2012-11-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.